Showing results (51-60 of 114) with videos related to
Sort By:
Pageof 12
International Journal of Oncology|June 6, 1998
nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic techniqueG Simone, A Mangia, S Petroni, et al.Cancer Clinical Trials|January 1, 1981
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgeryM De Lena, M Varini, R Zucali, et al.International Journal of Oncology|January 14, 2004
Rationale for the use of gemcitabine in breast cancer (Review)N Silvestris, M D'Aprile, G Andreola, et al.Haematologica|January 1, 1992
Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomasM De Lena, A Barletta, F Marzullo, et al.Haematologica|July 1, 1993
Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy)M De Lena, P Ditonno, V Lorusso, et al.Minerva Medica|July 1, 1992
[The determination of sialic acid in cancer patients]M Correale, I Abbate, G Gargano, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trialM De Lena, E Maiello, V Lorusso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot studyM De Lena, P Ditonno, V Lorusso, et al.International Journal of Oncology|June 14, 2002
Epithelial ovarian cancer: second and third line chemotherapy (review)A Latorre, M De Lena, A Catino, et al.Clinical & Experimental Metastasis|April 1, 1983
T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.Pageof 12